UKCGG is a national, multi-disciplinary organisation with membership including clinicians, genetic counsellors and scientists with an interest in the hereditary aspects of cancer. In 2020, the UKCGG published guidelines for the management of patients with LFS, which included recommendations for a UK-wide surveillance protocol.